Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lercanidipine/Valsartan Combination in Hypertension
NCT01928628Phase 3Completed
- Sponsor
- LG Chem
- Start
- May 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lercanidipine, valsartan in hypertension (HTN), sponsored by LG Chem. Started May 2012; status: completed.
02
Drugs
lercanidipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01928628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928628.